CeriBell, Inc (CBLL NASDAQ) stock market data APIs
$19.0269
-0.46(-2.4%)
as of July 3, 2025
Try our APIs with
free plan!
CeriBell, Inc Financial Data Overview
Price chart is built with
Anychart
CeriBell, Inc. operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States. The company develops Ceribell System, a novel and point-of-care electroencephalography (EEG) platform to address the unmet needs of patients in the acute care setting. It also offers disposable headbands consists of ten non-invasive electrodes pre-filled with conductive gel; and pocket-sized battery-operated recorders to record and store EEG signals generated by the headband. In addition, the company provides Clarity, an AI-powered seizure detection algorithm. Further, it operates Ceribell EEG portal, a cloud-based secured portal that enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.
Prev. Close
19.0269
Open
18.5688
High
19.0249
Low
18.7638
52 wk Range
10.01-32.749
Market Cap
768 M
Shares Outstanding
35 824 K
Revenue
60 041 K
EPS
-0.36
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get CeriBell, Inc data using free add-ons & libraries
Get CeriBell, Inc Fundamental Data
CeriBell, Inc Fundamental data includes:
- Net Revenue: 60 041 K
- EBITDA: -34 196 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-08
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
CeriBell, Inc News
New
CeriBell a new buy at BTIG on growth in EEG monitoring system
[The New York Stock Exchange on the Wall street sign] Dmitry Vinogradov BTIG has initiated CeriBell (NASDAQ:CBLL [https://seekingalpha.com/symbol/CBLL]) with a buy rating saying that the company's po...
BTIG initiates Ceribell stock with Buy rating on AI-driven EEG system
Investing.com - BTIG initiated coverage on Ceribell (NASDAQ:CBLL) Tuesday with a Buy rating and a $30.00 price target, citing the company’s point-of-care EEG monitoring system powered by proprietary...
Ceribell director Robertson sells $330k in shares
Director Rebecca B. Robertson of Ceribell, Inc. (CBLL), a medical technology company currently valued at $643 million, recently sold 18,633 shares of common stock for approximately $330,961. According...
Insider Sale: Director at $CBLL Sells 20,000 Shares
REBECCA B ROBERTSON, a director at $CBLL, sold 20,000 shares of the company on 06-16-2025 for an estimated $342,800. We received data on the trade from a recent SEC filing. This was a sale of approxim...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
